This Article Full Text Full Text (PDF) All Versions of this Article: 35/4/942    most recent 01.STR.0000122624.32167.e0v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ihara, M. Articles by Fukuyama, H. Search for Related Content PubMed PubMed Citation Articles by Ihara, M. Articles by Fukuyama, H. Related Collections Brain Circulation and Metabolism

(Stroke. 2004;35:942.)
© 2004 American Heart Association, Inc.

Original Contributions

Decrease in Cortical Benzodiazepine Receptors in Symptomatic Patients With Leukoaraiosis

A Positron Emission Tomography Study

M. Ihara, MD, PhD; H. Tomimoto, MD, PhD; K. Ishizu, MD, PhD; T. Mukai, PhD; H. Yoshida, MD; N. Sawamoto, MD, PhD; M. Inoue, MD; T. Doi, MD; K. Hashikawa, MD, PhD; J. Konishi, MD, PhD; H. Shibasaki, MD, PhD H. Fukuyama, MD, PhD

From the Department of Neurology (M.I., H.T., H.S.), the Horizontal Medical Research Organization (M.I.), the Department of Nuclear Medicine and Diagnostic Radiology (K.I., T.M., J.K.), and the Human Brain Research Center (H.Y., N.S., M.I., T.D., K.H., H.S., H.F.), Kyoto University Graduate School of Medicine, Shogoin, Sakyo, Kyoto, Japan; National Institute of Neurological Disorders and Stroke (H.S.), National Institutes of Health, Bethesda, Md.

Correspondence to Masafumi Ihara, MD, PhD. Kyoto University, Horizontal Medical Research Organization, Yoshida-Konoe, Sakyo, Kyoto, 606-8501, Japan. E-mail ihara{at}kuhp.kyoto-u.ac.jp

Background and Purpose— [¹¹C]flumazenil (FMZ), a ligand that selectively binds to the central benzodiazepine receptor in the neuronal membrane, is useful for evaluating neuronal viability in a positron emission tomography (PET) scan. Using this ligand, we investigated whether there was a correlation between neuronal integrity in various brain structures and dementia in patients with leukoaraiosis.

Methods— Twelve patients with extensive leukoaraiosis on magnetic resonance imaging were divided into groups of patients with or without dementia. Based on a 2-compartment, 2-parameter model that included metabolite-corrected arterial input and PET-measured cerebral radioactivity, the distribution volume of FMZ (FMZ-V_d) was calculated in various regions of interest by nonlinear curve fitting. Additionally, tracer kinetic analysis was applied for voxel-by-voxel quantification of FMZ-V_d, and data analysis was performed by statistical parametric mapping.

Results— The presence of dementia was associated with a reduced FMZ-V_d in widespread areas of the cerebral cortex, including the bilateral frontopolar and frontal/insular areas, the left temporo-occipital border areas, and the left marginal cortical areas.

Conclusions— Differences in neuronal integrity in the cerebral cortex might determine whether patients with leukoaraiosis become symptomatic or not.

Key Words: leukoaraiosis • Binswanger’s disease • receptors, benzodiazepine • tomography, emission computed

This article has been cited by other articles:

				H. Yamauchi, T. Kudoh, Y. Kishibe, J. Iwasaki, and S. Kagawa Selective Neuronal Damage and Borderzone Infarction in Carotid Artery Occlusive Disease: A 11C-Flumazenil PET Study J. Nucl. Med., December 1, 2005; 46(12): 1973 - 1979. [Abstract] [Full Text] [PDF]